222

CLOVER BIOPHARMACEUTICALS LTD

No trades
See on Supercharts

2197 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Clover Biopharmaceuticals Ltd. engages in the research and development of biopharmaceutical products. It is a global clinical-stage biotechnology company which engages in developing novel vaccines and biologic therapeutic candidates. The firm's Trimer-Tag technology platform is a product development platform for the creation of novel vaccines and biologic therapies. The company was founded on October 31, 2018 and is headquartered in Shanghai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

2197 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company